Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori

European Journal of Pharmacology

Volumn 345, Issue 2, 1998, Pages 193-198

  Ito, Yutaka ^a   Shibata, Kazuo ^b   Hongo, Aiko ^a   Kinoshita, Mine ^b  

^a Lead Generation Research Laboratory   (Japan)

^b Pharmaceutical Devmt Res Lab   (Japan)

Author keywords

Antiulcer drug; Ecabet sodium; Helicobacter pylori; Urease

Indexed keywords

12 SULFODEHYDROABIETIC ACID; BENZOHYDROXAMIC ACID; UREASE;

ARTICLE; BACTERIUM CULTURE; CONCENTRATION RESPONSE; ENZYME INHIBITION; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL;

ANTI-ULCER AGENTS; DITERPENES; DITERPENES, ABIETANE; HELICOBACTER PYLORI; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; UREASE;

EID: 0032546265     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01622-1     Document Type: Article

References (26)

1. Akamatsu S. Some micromethods for enzyme studies. J. Biochem. (Tokyo). 39:1952;203-210.
2. Dixon, M., Webb, E.C., 1979. Enzyme inhibition and activation. In: Dixon, M., Webb, E.C. (Eds.), 3rd edn., Enzyme. Academic Press, New York, pp. 332-344.
3. Dunn B.E., Campbell G.P., Perez-Perez G.P., Blaser M.J. Purification and characterization of urease from Helicobacter pylori. J. Biol. Chem. 265:1990;9464-9469.
4. Fukuda Y., Mizuta T., Yamamoto I., Tamura K., Shimoyama T. The novel anti-ulcer agent ecabet sodium (TA-2711) eradicates Helicobacter pylori colonizing on the gastric mucosa of Japanese monkeys. Scand. J. Gastroenterol. 29:1994;1055-1056.
5. Fukuda Y., Yamamoto I., Okui M., Tonokatsu Y., Shimoyama T. Combination therapies with a proton pump inhibitor for Helicobacter pylori-induced gastric ulcer patients. J. Clin. Gastroenterol. 20:1995;S132-S135. Suppl. 2.
6. Fukuda Y., Okui M., Yamamoto I., Tonokatsu Y., Sawada Y., Sakagami T., Shimoyama T. The suppressive effect on Helicobacter pylori of ecabet sodium using Japanese monkeys. Gut. Suppl. 2:1996;A11.
7. Isomoto H., Matsunaga K., Minamino Y., Takeo Y., Makiyama K. Evaluation of a new triple therapy (Lansoprazole and clarithromycin with ecabet) for eradication of H. pylori in patients with peptic ulcer. Jpn. Pharmacol. Ther. 23:1995;439-446. in Japanese.
8. Ito Y., Sugawara Y., Takaiti O., Nakamura S. Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6- sulfo-1-phenanthrencarboxylic acid 6-sodium salt pentahydrate (TA-2711): II. Distribution in the rat stomach. J. Pharmacobio-Dyn. 14:1991;547-554.
9. Ito Y., Nakamura S., Onoda Y., Sugawara Y., Takaiti O. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity: I. Inactivation of enzyme protein. Jpn. J. Pharmacol. 62:1993;169-174.
10. Ito Y., Onoda Y., Nakamura S., Tagawa K., Fukushima T., Sugawara Y., Takaiti O. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity: II. Interaction with substrate protein. Jpn. J. Pharmacol. 62:1993;175-181.
11. Ito Y., Hongo A., Kinoshita M., Tamaki H. Mechanism of anti-urease action by the anti-ulcer drug ecabet sodium. Biol. Pharm. Bull. 18:1995;850-853.
12. Kawano S., Tsujii M., Fusamoto H., Sato N., Kamada T. Chronic effect of intragastric ammonia on gastric mucosal structure in rats. Dig. Dis. Sci. 36:1991;33-38.
13. Kinoshita M., Iwasaki H., Yasoshima A., Tamaki H. Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats. Biol. Pharm. Bull. 16:1993;1220-1225.
14. Kobashi K., Hase J., Uehara K. Specific inhibition of urease by hydroxamic acids. Biochim. Biophys. Acta. 65:1962;380-383.
15. Labenz J., Borsh G. Role of Helicoacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion. 55:1994;19-23.
16. Lee A., Fox J., Hazell S. Pathogenicity of Helicobacter pylori: a perspective. Infect. Immun. 61:1993;1601-1610.
17. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. i:1984;1311-1315.
18. Marshall B.J., Barrett L.J., Prakash C., McCallum R.W., Guerrant R.L. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology. 99:1990;697-702.
19. Mobley H.L.T., Hu L.-T., Foxall P.A. Helicobacter pylori urease: Properties and role in pathogenesis. Scand. J. Gastroenterol. Suppl. 187:1991;39-46.
20. Onoda Y., Magaribuchi T., Tamaki H. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcer in rats. Jpn. J. Pharmacol. 51:1989;65-73.
21. Onoda Y., Takido M., Magaribuchi T., Tamaki H. Effect of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats. Jpn. J. Pharmacol. 52:1990;631-638.
22. Raus E.A.J., Tygat G.N.J. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. i:1990;1233-1235.
23. Shibata K., Ito Y., Hongo A., Yasoshima A., Endo T., Ohashi M. Bactericidal activity of a new antiulcer agent, ecabet sodium, against Helicobacter pylori under acidic conditions. Antimicrob. Agents Chemother. 39:1995;1295-1299.
24. Triebling A.T., Korsten M.A., Dlugosz J.W., Pronetto F., Lieber C.S. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig. Dis. Sci. 36:1991;1089-1096.
25. Tsujii M., Kawano S., Tsuji S., Fusamoto H., Kamada T., Sato N. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology. 102:1992;1881-1888.
26. Warren J.R., Marshall B.J. Unidentified curved bacilli on gastric epithelium chronic gastritis. Lancet. i:1983;1273-1275.